iTechDachs:
Und ein kurzer Artikel dazu
19.11.18 14:48
Marlborough startup drugmaker RXI Pharmaceuticals now has a runway extending into 2020 as the company continues to reinvent itself and rebrand into a pharmaceutical firm focused on fighting cancer.
Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +146,65%
Xtrackers Nikkei 225 UCITS ETF 2D - EUR Hedged
Perf. 12M: +55,04%
Xtrackers CSI500 Swap UCITS ETF 1C
Perf. 12M: +53,94%
Xtrackers MSCI EM Latin America ESG Swap UCITS ETF 1C
Perf. 12M: +49,22%
Xtrackers MSCI Brazil UCITS ETF 1C
Perf. 12M: +48,60%
Zurück
